Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1907 USD | -0.21% | +27.13% | -83.00% |
Financials (USD)
Sales 2024 * | 52.3M | Sales 2025 * | 56.45M | Capitalization | 6.22M |
---|---|---|---|---|---|
Net income 2024 * | -9M | Net income 2025 * | -5M | EV / Sales 2024 * | 0.12 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.11 x |
P/E ratio 2024 * |
-0.6
x | P/E ratio 2025 * |
-1.74
x | Employees | 157 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on BIOLASE, Inc.
1 day | -0.21% | ||
1 week | +27.13% | ||
Current month | +38.19% | ||
1 month | +37.69% | ||
3 months | -84.24% | ||
6 months | -89.41% | ||
Current year | -83.00% |
Managers | Title | Age | Since |
---|---|---|---|
John Beaver
CEO | Chief Executive Officer | 62 | 17-09-30 |
Director of Finance/CFO | 53 | 21-01-31 | |
Steven Sandor
COO | Chief Operating Officer | 44 | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan T. Lord
CHM | Chairman | 69 | 14-07-31 |
John Beaver
CEO | Chief Executive Officer | 62 | 17-09-30 |
Director/Board Member | 73 | 21-08-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.1907 | -0.21% | 5 672 935 |
24-03-27 | 0.1911 | +19.21% | 10,108,691 |
24-03-26 | 0.1603 | -5.71% | 3,803,743 |
24-03-25 | 0.17 | -5.19% | 9,181,396 |
24-03-22 | 0.1793 | +19.53% | 131,373,307 |
Delayed Quote Nasdaq, March 28, 2024 at 03:47 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.00% | 6.22M | |
+9.52% | 221B | |
+8.15% | 184B | |
+18.20% | 142B | |
+18.87% | 101B | |
+7.83% | 68.07B | |
+25.46% | 57.27B | |
-3.69% | 47.42B | |
+5.18% | 43.19B | |
+15.20% | 28.84B |